Celldex (CLDX) announced the appointment of Teri Lawver as Senior Vice President, Chief Commercial Officer. Lawver is a global healthcare executive with 30 years of leadership experience. Lawver succeeds Richard Wright, who will retire from Celldex.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLDX:
- Celldex’s Promising Phase II Trial Results Justify Buy Rating
- Celldex’s Promising Phase 2 Trial Results and Strong Financial Position Support Buy Rating
- Celldex’s Barzolvolimab Shows Promising Phase 2 Results, Justifying Buy Rating
- Celldex announces additional data on barzolvolimab
- Celldex presents results from Barzolvolimab Phase 2 Study in ColdU, SD